I hope that we can come to a bipartisan agreement and find the offsets needed.
Identifying COVID-19 origins would provide greater clarity into not only the causes of the current pandemic but also the vulnerabilities to ...
Let me be clear. The work that this Subcommittee is conducting is critical to ensure that the destruction that was caused by the outbreak of...
And I encourage you to continue to offer those in-person meetings. As we put the pandemic in the rearview mirror, it is time to resume that ...
I realize my time has expired, and I would ask you to take consideration to allow all patients to have access to FDA-approved drugs.
Unfortunately, Democrats' so-called Inflation Reduction Act threatens the continued success of the Orphan Drug Act.
As a physician, I believe that we must do more, not impede the pipeline of new life-altering therapies for patients living with rare disease...
But right now patients in rural areas who do not have access to tertiary facilities are not eligible to receive this important life-altering...
I don't think there is anything that hospitals should be afraid of when it comes to 340B transparency.
the 340B drug-pricing program was created in 1992 and aimed at enabling certain healthcare providers known as covered entities--and this is ...
I agree that that full investigation of a lab origin is the responsibility of this committee.